Dan S. Hogdall

Herlev, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Remission of metastatic duodenal cancer after treatment with BRAF inhibitor

Remission of metastatic duodenal cancer after treatment with BRAF inhibitor

Journal: Ugeskrift for laeger

Published: January 30, 2026

Molecular and cellular consequences of tumour-autonomous IL-6 signalling in intrahepatic cholangiocarcinoma.

Molecular and cellular consequences of tumour-autonomous IL-6 signalling in intrahepatic cholangiocarcinoma.

Journal: Gut

Published: November 14, 2025

Personalized Neoadjuvant Chemotherapy for Gastrointestinal Cancers: Shaping Imprecision to be Precise.

Personalized Neoadjuvant Chemotherapy for Gastrointestinal Cancers: Shaping Imprecision to be Precise.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 22, 2024

Targeted therapies in biliary tract cancer-when precision becomes imprecise.

Targeted therapies in biliary tract cancer-when precision becomes imprecise.

Journal: ESMO gastrointestinal oncology

Published: August 13, 2024

Molecularly redefining small bowel adenocarcinoma to accelerate precision patient care - protocol of a multicenter observational cohort biomarker study.

Molecularly redefining small bowel adenocarcinoma to accelerate precision patient care - protocol of a multicenter observational cohort biomarker study.

Journal: BMC cancer

Published: February 02, 2024

Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy.

Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy.

Journal: Gut

Published: July 26, 2023

Protein Signatures and Individual Circulating Proteins, including IL-6 and IL-15, Associated with Prognosis in Patients with Biliary Tract Cancer.

Protein Signatures and Individual Circulating Proteins, including IL-6 and IL-15, Associated with Prognosis in Patients with Biliary Tract Cancer.

Journal: Cancers

Published: December 13, 2022

Blood-based tumor fibrosis markers as diagnostic and prognostic biomarkers in patients with biliary tract cancer.

Blood-based tumor fibrosis markers as diagnostic and prognostic biomarkers in patients with biliary tract cancer.

Journal: International journal of cancer

Published: August 16, 2022

Molecular therapeutic targets for cholangiocarcinoma: Present challenges and future possibilities.

Molecular therapeutic targets for cholangiocarcinoma: Present challenges and future possibilities.

Journal: Advances in cancer research

Published: August 12, 2022

MicroRNA-27a-3p targets FoxO signalling to induce tumour-like phenotypes in bile duct cells.

MicroRNA-27a-3p targets FoxO signalling to induce tumour-like phenotypes in bile duct cells.

Journal: Journal of hepatology

Published: March 29, 2022

Genomic landscape of treatment refractory metastatic colorectal cancer.

Genomic landscape of treatment refractory metastatic colorectal cancer.

Journal: Acta oncologica (Stockholm, Sweden)

Published: October 04, 2021

Whole blood microRNAs capture systemic reprogramming and have diagnostic potential in patients with biliary tract cancer.

Whole blood microRNAs capture systemic reprogramming and have diagnostic potential in patients with biliary tract cancer.

Journal: Journal of hepatology

Published: September 29, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026